Lidoflazine

Chemical formula: C₃₀H₃₅F₂N₃O  Molecular mass: 491.275 g/mol  PubChem compound: 3926

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
C08EX01 Lidoflazine C Cardiovascular system → C08 Calcium channel blockers → C08E Non-selective calcium channel blockers → C08EX Other non-selective calcium channel blockers
Discover more medicines within C08EX01

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 3416-26-0
DrugBank Drug: DB13766
KEGG Drug: D04733
PubChem Compound: 3926
RxNorm Ingredient: 6390
SNOMED-CT Concept: 418865004
Lidoflazine (substance)
UNII Identifier: J4ZHN3HBTE
LIDOFLAZINE

Medicines

Lidoflazine is an active ingredient of these brands:

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈